Fennec Pharmaceuticals Inc 10-K for FY2023
Fennec Pharmaceuticals Inc. (FENC)
10-K
2024-03-29
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 10-K
Fennec Pharmaceuticals Inc filed this 10-K on March 29, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $21.25M
- up 1284.5% from $1.54M a year earlier
- Net loss
- $16.05M
- compared with a net loss of $23.71M a year earlier
- Diluted EPS
- -$0.60
- compared with -$0.90 a year earlier